Nurix Therapeutics Company
Nurix develops small molecule inhibitors for the treatment of proliferative and degenerative diseases.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2012
Employees Number:
101-250
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Register and Claim Ownership